These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia. Tatò F, Keller C, Wolfram G. Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818 [Abstract] [Full Text] [Related]
10. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia. van Barlingen HH, Kock LA, de Man FH, Erkelens DW, de Bruin TW. Atherosclerosis; 1996 Mar; 121(1):75-84. PubMed ID: 8678926 [Abstract] [Full Text] [Related]
13. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR. Arteriosclerosis; 1989 Mar; 9(3):335-44. PubMed ID: 2497719 [Abstract] [Full Text] [Related]
14. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V. Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028 [Abstract] [Full Text] [Related]
16. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype. Georgieva AM, van Greevenbroek MM, Krauss RM, Brouwers MC, Vermeulen VM, Robertus-Teunissen MG, van der Kallen CJ, de Bruin TW. Arterioscler Thromb Vasc Biol; 2004 Apr 24; 24(4):744-9. PubMed ID: 14751815 [Abstract] [Full Text] [Related]
17. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Kwiterovich PO, White S, Forte T, Bachorik PS, Smith H, Sniderman A. Arteriosclerosis; 1987 Apr 24; 7(3):211-25. PubMed ID: 3593067 [Abstract] [Full Text] [Related]
18. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. Guérin M, Bruckert E, Dolphin PJ, Turpin G, Chapman MJ. Arterioscler Thromb Vasc Biol; 1996 Jun 24; 16(6):763-72. PubMed ID: 8640404 [Abstract] [Full Text] [Related]